Cargando…
Genomics-driven drug discovery based on disease-susceptibility genes
Genome-wide association studies have identified numerous disease-susceptibility genes. As knowledge of gene–disease associations accumulates, it is becoming increasingly important to translate this knowledge into clinical practice. This challenge involves finding effective drug targets and estimatin...
Autores principales: | Sonehara, Kyuto, Okada, Yukinori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944616/ https://www.ncbi.nlm.nih.gov/pubmed/33691789 http://dx.doi.org/10.1186/s41232-021-00158-7 |
Ejemplares similares
-
Obelisc: an identical-by-descent mapping tool based on SNP streak
por: Sonehara, Kyuto, et al.
Publicado: (2020) -
A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis
por: Namba, Shinichi, et al.
Publicado: (2022) -
Estimating gene-level false discovery probability improves eQTL statistical fine-mapping precision
por: Wang, Qingbo S, et al.
Publicado: (2023) -
Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis
por: Sato, Go, et al.
Publicado: (2023) -
Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2023)